Clinical and Experimental Hepatology
eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
3/2025
vol. 11
 
Share:
Send email
Share:
Review paper

Implantation of nasobiliary drainage in treatment of severe episodes of benign recurrent intrahepatic cholestasis (BRIC) in pediatric patients

Maciej Dądalski
1
,
Tetiana Wojciechowska
1
,
Joanna Ryżko
1
,
Magda Naorniakowska
1
,
Joanna Cielecka-Kuszyk
2
,
Elżbieta Ciara
3
,
Małgorzata Sawilska-Tańska
4
,
Joanna Pawłowska
1

  1. Department of Gastroenterology, Hepatology, Nutritional Disorders, and Pediatrics, The Children’s Memorial Health Institute, Warsaw, Poland
  2. Department of Pathomorphology, Children’s Memorial Health Institute, Warsaw, Poland
  3. Department of Medical Genetics, Children’s Memorial Health Institute, Warsaw, Poland
  4. Department of Pediatrics, Infectious Diseases and Hepatology, The Tadeusz Browicz Provincial Hospital for Infectious Diseases and Observation in Bydgoszcz, Poland
Clin Exp HEPATOL 2025; 11, 3: 228–231
DOI: https://doi.org/10.5114/ceh.2025.153806
Online publish date: 2025/09/04
Article file
- Implantation.pdf  [0.09 MB]
Get citation
 
PlumX metrics:
 
1. Summerskill WHJ, Walshe JM. Benign recurrent intrahepatic obstructive jaundice. Lancet 1959; 1: 686-690.
2. van Ooteghem NAM, Klomp LWJ, van Berge-Henegouwen GP, Houwen RHJ. Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis:low GGT cholestasis is clinical continuum. J Hepatol 2002; 36: 439-443.
3. van Mil SW, Houwen RH, Klomp LW. Genetics of familial intrahepatic cholestasis syndromes. J Med Genet 2005; 42: 449-463.
4. van Mil SW, van der Woerd WL, van der Brugge G, et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004; 127: 379-384.
5. Stapelbroek JM, Van Erpecum KJ, Klomp LW, Houwen RH. Liver disease associated with canalicular transport defects: current and future therapies. J Hepatol 2010; 52: 258-271.
6. Parolin MB, Langowiski AR, Ioshii SO, et al. Benign recurrent intrahepatic cholestasis: a seven-year follow-up report. Arq Gastroenterol 2000; 37: 231-234.
7. Uegaki S, Tanaka A, Mori Y, et al. Successful treatment with colestimide for a bout of cholestasis in a Japanese patient with benign recurrent intrahepatic cholestasis caused by ATP8B1 mutation. Intern Med 2008; 47: 599-602.
8. Nicolás I, Pons JA, Vargas A, et al. Ursodeoxycholic acid treatment shortens the course of cholestasis in two patients with benign recurrent intrahepatic cholestasis. Gastroenterol Hepatol 2003; 26: 421-423.
9. Metzelder ML, Petersen C, Melter M, Ure BM. Modified laparoscopic external biliary diversion for benign recurrent intrahepatic cholestasis in obese adolescents. Pediatr Surg Int 2006; 22: 551-553.
10. Mezey E, Burns C, Burdick JF, Braine HG. A case of severe benign intrahepatic cholestasis treated with liver transplantation. Am J Gastroenterol 2002; 97: 475-477.
11. Stapelbroek JM, van Erpecum KJ, Klomp LW, et al. Nasobiliary drainage induces long-lasting remission in benign recurrent intrahepatic cholestasis. Hepatology 2006; 43: 51-53.
12. Huster D, Schubert C, Achenbach H, et al. Successful clinical application of extracorporal albumin dialysis in a patient with benign recurrent intrahepatic cholestasis (BRIC). J Gastroenterol 2001; 39 (Suppl 2): 13-14.
13. Sturm E, Franssen CF, Gouw A, et al. Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC). Liver 2002; 22 (Suppl 2): 72-75.
14. Kamińska-Gocał D, Ołdakowska-Jedynak U, Hartleb M, et al. Treatment of benign recurrent intrahepatitic cholestasis with extracorporeal liver support therapy (MARS and Prometheus) – clinical experience with two cases. E&C Hepatology 2011; 7: 60-62.
15. Kalicinski PJ, Ismail H, Jankowska I, et al. Surgical treatment of progressive familial intrahepatic cholestsis: comparison of partali external biliary diversion and ileal bypass. Eur J Pediatr Surg 2003; 13: 307-311.
16. Toros AB, Ozerdenen F, Bektaş H, Sari ND. A case report: nasobiliary drainage inducing remission in benign recurrent intrahepatic cholestasis. Turk J Gastroenterol 2012; 23: 75-78.
17. Wakui N, Fujita M, Oba N, et al. Endoscopic nasobiliary drainage improves jaundice attack symptoms in bening recurrent intrahepatic cholestasis: A case report. Exp Ther Med 2013; 5: 389-394.
18. Holz R, Kremer AE, Lütjohann D, et al. Can genetic testing guide the therapy of cholestatic pruritus? A case of benign recurrent intrahepatic cholestasis type 2 with severe nasobiliary drainage-refractory itch. Hepatol Commun 2018; 2: 152-154.
19. Zellos A, Lykopoulou L, Polydorou A, et al. Nasobiliary drainage in an episode of intrahepatic cholestasis in a child with mild ABCB11 disease. JPGN 2012; 55: 88-90.
20. Choudhury A, Kulkarni AV, Sahoo B, Bihari C. Endoscopic nasobiliary drainage: an effective treatment option for benign recurrent intrahepatic cholestasis (BRIC). BMJ Case Rep 2017: bcr2016218874.
21. Yakar T, Demir M, Gokturk HS, et al. Nasobiliary drainage for benign recurrent intrahepatic cholestasis in patients refractory to standard therapy. Clin Invest Med 2016; 39: 164-172.
22. Appleby VJ, Hutchinson JM, Davies MH. Safety and efficacy of long-term nasobiliary drainage to treat intractable pruritus in cholestatic liver disease. Frontline Gastroenterol 2015; 6: 252-254.
23. Hayashi H, Naoi S, Hirose Y, et al. Successful treatment with 4-phenylbutyrate in a patient with benign recurrent intrahepatic cholestasis type 2 refractory to biliary drainage and bilirubin absorption. Hepatol Res 2016; 46: 192-200.
24. Geladari EV, Vallianou NG, Margellou E, et al. Benign recurrent intrahepatic cholestasis: Where are we now? Gastroenterology Insights 2024; 15: 156-167.
Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.